Inclusion Criteria:

- Diagnosis of ischemic stroke defined as acute brain, spinal cord, or retinal
infarction based on objective evidence on imaging (such as a focal area of restricted
diffusion on Magnetic Resonance Imaging [MRI]) in a defined vascular distribution or
clinical evidence of focal ischemic injury based on symptoms persisting > 24 hours; or
spontaneous hemorrhagic stroke defined as a focal collection of blood within the brain
parenchyma that is non-traumatic and identified by brain computed tomography (CT) or
brain MRI

- Age ≥18 years

- Discharged directly home from acute care or inpatient rehabilitation

- SBP>130 at the post-acute clinic visit (within 21 days of discharge) & at Study Visit
1 (within 31 days of discharge)

- Able to read and understand English or Spanish

- Have access to a functioning smartphone or tablet with broadband access (required for
the intervention)

- Willing to install and use a study-compatible physical activity monitoring application
on their smartphone or smartphone of a qualifying caregiver

- Stated agreement to participate in either intervention to which they are assigned and
attend all required study visits

- Consent to receiving Short Message Service (SMS) required as part of the study
interventions

- Provision of a signed and dated informed consent form

Exclusion Criteria:

- Subdural hematoma or subarachnoid hemorrhage

- Current participation in another stroke clinical trial precluding dual enrollment

- Presence of terminal illness, such as cancer, that limits life expectancy to <1 year

- Diagnosis of end-stage renal disease defined as permanent kidney dysfunction requiring
the use of hemodialysis or peritoneal dialysis

- Pregnancy, lactation or planning to become pregnant

- Late-stage Alzheimer's disease or related dementia

- Transitioned to a facility such as skilled nursing or long-term care prior to
enrollment

- Any condition that in the opinion of the study investigator would preclude the
participant from being able to safely participate in the trial

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 2/05/2024. Questions regarding updates should be directed to the study team contact.